Key facts
- Certuma’s last known valuation is $60.0M (Mar 2026).
- It has raised $10.0M; the latest was Seed Round ($10.0M) in Mar 2026.
- Notable investors include 8VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Certuma
- ·The full record, as it builds
Funding rounds
No funding rounds for Certuma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Certuma
Developer of a clinical artificial intelligence platform designed to create an AI doctor capable of diagnosing and prescribing treatments for common medical conditions. The company offers a dual-layered AI architecture that combines generative models with a deterministic safety layer based on explicit clinical rules, enabling customers to access immediate, legally recognized medical diagnoses and prescriptions for low-risk conditions without the typical delays of traditional primary care.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2024
- Website
- certuma.ai/
- Ownership
- Privately Held (backing)
Certuma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Certuma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Certuma in its N-PORT filings yet. We sweep new filings monthly.